Creatine Is the New Collagen: How Longevity Science Is Rewriting the Supplement Stack

Key insights

• Creatine is following collagen's commercial playbook — moving from an ingredient confined to sports use into beauty-from-within, women's wellness, and daily supplement routines — and industry analysts now explicitly compare its trajectory to collagen's mainstream rise.
• The global creatine market is currently valued at $1.11 billion and is projected to reach $4.21 billion by 2030, growing at a CAGR of 25.2% — driven by expansion beyond athletic use into cognitive health, women's wellness, and longevity.
• More than 50% of new supplement products launched since July 2024 carry a healthspan claim, according to Mintel — signaling a category-wide reorientation toward functional longevity, and opening the window for creatine, NAD+, and C15:0 to follow collagen's path to mass market.

What's happening: Creatine — long established as a sports supplement with thirty years of performance research behind it — is being repositioned as a longevity and cognitive health ingredient, following the same commercial trajectory that collagen completed between 2015 and 2022. New research links creatine to working memory, age-related muscle preservation, and cellular energy metabolism, independent of athletic use. Brands in women's wellness and beauty-from-within have already begun incorporating it into daily supplement formulations. The transition is underway before most retail buyers and brand managers have registered it as a category shift.

From Sports Performance to Longevity: How Creatine's Research Base Expanded

Creatine monohydrate has been one of the most studied sports supplements on the market for thirty years. The evidence base for its performance effects — increased phosphocreatine stores, improved high-intensity output, faster muscle recovery — is not in question. But that evidence base also confined it. "Creatine" conjured a specific image: powder tubs, pre-workout rituals, men training for mass. It was effective and it was niche, and the niche kept it there.

What changed is the research question. Longevity scientists stopped asking "does creatine improve athletic performance?" and started asking "what does creatine do for cognitive function, bone density, and cellular energy metabolism across the lifespan?" The answers have been significant enough to pull creatine out of the supplement aisle and into a different conversation.

Studies now associate creatine supplementation with improved working memory and processing speed, particularly in sleep-deprived individuals and older adults. Research published in 2023 and 2024 points to its role in mitigating age-related muscle loss — sarcopenia — independent of exercise. HUM Nutrition's 2026 Wellness Trend report lists creatine as one of its top ingredients to watch, specifically in the context of women's health and cognitive support, two categories that had essentially no creatine presence five years ago.

Not everyone is convinced, however. The European Food Safety Authority (EFSA) reviewed creatine's cognitive claims in 2024 and found the supporting evidence "weak" for healthy adults at standard doses — with consistent effects appearing primarily at high doses (20g/day) or in specific populations such as older adults and the severely sleep-deprived. Long-term human healthspan data does not yet exist. A 2025 critical review published in ScienceDirect went further, noting that commercial enthusiasm for creatine as a cognitive enhancer has "far exceeded the strength of the supporting evidence." These are legitimate cautions. They are also, notably, a close echo of how collagen was discussed in 2017 and 2018 — when the market was already moving while scientists were still debating the evidence base. Whether that parallel ultimately validates or undermines the category is a question the next decade of research will answer. What it does not change is the commercial momentum already underway.

This is the same pattern collagen followed. Around 2018, a structural protein that orthopedic surgeons had discussed for decades landed in coffee, smoothies, and eventually drugstore shelves. Brands like Vital Proteins and Ancient Nutrition stripped away the clinical framing, gave it a lifestyle identity, and built a category that now generates over $1 billion annually in the US alone. The science didn't change. The cultural and commercial framing did. Creatine is following the same path. As Kyle Crowley, an ingredient specialist quoted by FoodNavigator, put it in 2025: "I believe we'll soon see it in the same category as supplements like collagen or magnesium — something people enjoy daily not just for one specific outcome, but for overall wellbeing."

Why Consumers Are Buying Differently: The Healthspan Shift

What's enabling these ingredient transitions is a structural shift in what consumers expect wellness to do. According to Glanbia Nutritionals' 2026 megatrends report, the dominant consumer wellness framework has moved from lifespan extension — living longer — to healthspan optimization: maintaining cognitive sharpness, physical capacity, and metabolic resilience across decades.

This matters because it changes the purchase logic. A collagen supplement sold on the promise of younger-looking skin is a beauty product with a wellness halo. A creatine supplement sold on the promise of sustained cognitive function and muscle preservation into your 60s is a prevention strategy — a different product category with different purchase frequency and customer retention dynamics.

Mintel's 2026 functional ingredients report documents this shift at the SKU level: more than 50% of new supplement launches since July 2024 carry at least one healthspan claim. The "healthspan-conscious professional" — not the biohacker, not the elite athlete, but the informed 35-to-55-year-old who wants functional longevity without clinical complexity — is now the primary addressable market for a growing share of the supplement and functional food category.

Three Ingredients to Watch

Creatine is the leading edge. Its mainstream crossover is already underway: beauty-from-within brands are incorporating it into skin-support and cognitive-health formulations, and women's wellness brands have quietly added it to daily supplement stacks without the sports marketing vocabulary. Brands that wait until creatine is a standard shelf item to build their positioning will be entering a crowded category, not a nascent one.

NAD+ variants — nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — are slightly earlier in the cycle but moving quickly. These compounds play a central role in cellular energy production and DNA repair; their decline with age is one of the more robust findings in longevity biology. They now appear on over 10% of all healthspan supplement launches tracked since mid-2024. The challenge for brands is translation: NAD+ precursors require more consumer education than creatine, but the market appetite for ingredients with a cellular mechanism is growing.

C15:0 — pentadecanoic acid — is the most nascent of the three, and potentially the highest-upside. An odd-chain saturated fatty acid found in trace amounts in dairy fat and certain fish, C15:0 is emerging as a longevity ingredient with evidence across metabolic health, cellular membrane stability, and mitochondrial function. Hone Health's 2026 longevity trends analysis positions it as the ingredient most likely to achieve omega-3-level mainstream awareness in the near term. Omega-3 is a $4 billion annual supplement category in the US. C15:0 is currently known to a fraction of that audience. The brand that builds the consumer education narrative on C15:0 before mainstream arrival owns the category positioning.

The Strategic Window: Building Position Before the Category Goes Mass

The nutricosmetics market — beauty from within, ingestible wellness — is already converging with functional supplementation. NutraIngredients' March 2026 analysis of nutricosmetics trends identifies the integration of longevity-positioned ingredients into skin-health formulations as one of the defining brand moves of 2026. Collagen normalized the category. Creatine, NAD+, and C15:0 are set to expand it.

The brands that built lasting category authority in collagen — Vital Proteins, Ancient Nutrition, Reserveage — did so before it became a Costco item. They built the consumer vocabulary, the aesthetic, and the cultural permission structure. By the time the category went mass, the origin story was already written and the shelf position was established.

The equivalent window exists now for creatine, NAD+, and C15:0. Brands in beauty, food, and wellness that begin building ingredient education and product positioning in 2026 are entering at the same stage Vital Proteins entered collagen in 2016. Those that wait for mass-market validation will find the positioning already occupied.